Systolic Hypertension in Older Persons: How Aggressive Should Treatment Be?

Progress in Cardiovascular Diseases

Volumn 48, Issue 6, 2006, Pages 397-406

  Kapoor, John R ^a,b   Chaudry, Sarwat ^a,b   Agostini, Joseph V ^a,b   Foody, Jo Anne Micale ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; LOSARTAN; NITRENDIPINE; PLACEBO; RESERPINE; THIAZIDE DIURETIC AGENT;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CLINICAL TRIAL; COGNITION; CONFIDENCE INTERVAL; COUGHING; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; EDEMA; ELDERLY CARE; FLUSHING; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INCIDENCE; MEDICAL DECISION MAKING; META ANALYSIS; MORTALITY; PHYSICIAN; QUALITY OF LIFE; QUESTIONNAIRE; RISK FACTOR; SIDE EFFECT; STROKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPERTENSION; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 33646576477     PISSN: 00330620     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcad.2006.02.006     Document Type: Article

References (71)

1. Chobanian A.V., Bakris G.L., Black H.R., et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289 (2003) 2560-2572
2. Borzecki A.M., Wong A.T., Hickey E.C., et al. Hypertension control: How well are we doing?. Arch. Intern. Med. 163 (2003) 2705-2711
3. Hollenberg N.K., Williams G.H., Anderson R., et al. Symptoms and the distress they cause: Comparison of an aldosterone antagonist and a calcium channel blocking agent in patients with systolic hypertension. Arch. Intern. Med. 163 (2003) 1543-1548
4. The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med. 140 (1980) 1280-1285
5. The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med. 144 (1984) 1045-1057
6. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med. 148 (1988) 1023-1038
7. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch. Intern. Med. 153 (1993) 154-183
8. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med. 157 (1997) 2413-2446
9. Shekelle R.B., Ostfeld A.M., and Klawans Jr. H.L. Hypertension and risk of stroke in an elderly population. Stroke 5 (1974) 71-75
10. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group. JAMA 265 (1991) 3255-3264
11. Staessen J.A., Fagard R., Thijs L., et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet 350 (1997) 757-764
12. Liu L., Wang J.G., Gong L., et al. Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group. J. Hypertens. 16 (1998) 1823-1829 (12 Pt 1)
13. Kjeldsen S.E., Dahlof B., Devereux R.B., et al. Effects of losartan on cardiovascular morbidity and mortality in patients with isolated systolic hypertension and left ventricular hypertrophy: A Losartan Intervention for Endpoint Reduction (LIFE) substudy. JAMA 288 (2002) 1491-1498
14. Savage P.J., Pressel S.L., Curb J.D., et al. Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: The Systolic Hypertension in the Elderly Program. SHEP Cooperative Research Group. Arch. Intern. Med. 158 (1998) 741-751
15. Applegate W.B., Pressel S., Wittes J., et al. Impact of the treatment of isolated systolic hypertension on behavioral variables. Results from the Systolic Hypertension in the Elderly Program. Arch. Intern. Med. 154 (1994) 2154-2160
16. Forette F., Seux M.L., Staessen J.A., et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352 (1998) 1347-1351
17. Fletcher A.E., Bulpitt C.J., Thijs L., et al. Quality of life on randomized treatment for isolated systolic hypertension: Results from the Syst-Eur Trial. J. Hypertens. 20 (2002) 2069-2079
18. Bulpitt C.J., Beckett N.S., Fletcher A.E., et al. Withdrawal from treatment in the Syst-Eur Trial. J. Hypertens. 20 (2002) 339-346
19. Perry H.M., Smith W.M., McDonald R.H., et al. Morbidity and mortality in the Systolic Hypertension in the Elderly Program (SHEP) pilot study. Stroke 20 (1989) 4-13
20. Gueyffier F., Bulpitt C., Boissel J.-P., et al. Antihypertensive drugs in very old people: A subgroup meta-analysis of randomised controlled trials. Lancet 353 (1999) 793-796
21. Hyman D.J., and Pavlik V.N. Characteristics of patients with uncontrolled hypertension in the United States. N. Engl. J. Med. 345 (2001) 479-486
22. Sagie A., Larson M.G., and Levy D. The natural history of borderline isolated systolic hypertension. N. Engl. J. Med. 329 (1993) 1912-1917
23. O'Donnell C.J., Ridker P.M., Glynn R.J., et al. Hypertension and borderline isolated systolic hypertension increase risks of cardiovascular disease and mortality in male physicians. Circulation 95 (1997) 1132-1137
24. Duthie E.H., and Katz P.R. Practice of geriatrics. 3rd ed. (1998), Saunders, Philadelphia
25. U.S. Bureau of the Census. Current population reports, projections of the United States by age, sex, race, and Hispanic origin: 1992 to 2050 (1992), U.S. Government Printing Office, Washington, DC
26. Psaty B.M., Furberg C.D., Kuller L.H., et al. Traditional risk factors and subclinical disease measures as predictors of first myocardial infarction in older adults: The Cardiovascular Health Study. Arch. Intern. Med. 159 (1999) 1339-1347
27. Staessen J.A., Fagard R., Thijs L., et al. Subgroup and per-protocol analysis of the randomized European Trial on Isolated Systolic Hypertension in the Elderly. Arch. Intern. Med. 158 (1998) 1681-1691
28. Bulpitt C.J., Beckett N.S., Cooke J., et al. Results of the pilot study for the Hypertension in the Very Elderly Trial. J. Hypertens. 21 (2003) 2409-2417
29. Appel L.J., Moore T.J., Obarzanek E., et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N. Engl. J. Med. 336 (1997) 1117-1124
30. Sacks F.M., Svetkey L.P., Vollmer W.M., et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N. Engl. J. Med. 344 (2001) 3-10
31. Moore T.J., Conlin P.R., Ard J., et al. DASH (Dietary Approaches to Stop Hypertension) diet is effective treatment for stage 1 isolated systolic hypertension. Hypertension 38 (2001) 155-158
32. Blumenthal J.A., Sherwood A., Gullette E.C., et al. Exercise and weight loss reduce blood pressure in men and women with mild hypertension: Effects on cardiovascular, metabolic, and hemodynamic functioning. Arch. Intern. Med. 160 (2000) 1947-1958
33. Ferrier K.E., Waddell T.K., Gatzka C.D., et al. Aerobic exercise training does not modify large-artery compliance in isolated systolic hypertension. Hypertension 38 (2001) 222-226
34. Messerli F.H., Grossman E., and Goldbourt U. Are {beta}-blockers efficacious as first-line therapy for hypertension in the elderly?: A systematic review. JAMA 279 (1998) 1903-1907
35. MacGregor G.A., Markandu N.D., Banks R.A., et al. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol. BMJ 284 (1982) 693-696
36. Frishman W.H., Bryzinski B.S., Coulson L.R., et al. A multifactorial trial design to assess combination therapy in hypertension. Treatment with bisoprolol and hydrochlorothiazide. Arch. Intern. Med. 154 (1994) 1461-1468
37. Zezulka A.V., Gill J.S., and Beevers D.G. The effects of bendroflumethiazide added to nifedipine in patients with hypertension. J. Clin. Pharmacol. 27 (1987) 41-45
38. MacGregor G.A., and Cappuccio F.P. Lack of effect of a diuretic added to diltiazem. J. Hum. Hypertens. 11 (1997) 249-250
39. Lloyd-Jones D.M., Evans J.C., and Levy D. Hypertension in adults across the age spectrum: Current outcomes and control in the community. JAMA 294 (2005) 466-472
40. Boyd C.M., Darer J., Boult C., et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 294 (2005) 716-724
41. Gurwitz J.H., Field T.S., Harrold L.R., et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 289 (2003) 1107-1116
42. Tinetti M.E., Bogardus Jr. S.T., and Agostini J.V. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N. Engl. J. Med. 351 (2004) 2870-2874
43. Charles C., Whelan T., and Gafni A. What do we mean by partnership in making decisions about treatment?. BMJ 319 (1999) 780-782
44. Berwick D. A user's manual for the IOM's eQuality Chasmf report. Health Aff. (Millwood) 3 (2002) 80-90
45. Sheridan S., Harris R., Woolf S., and Force SD-MWotUSPST. Shared decision making about screening and chemoprevention A suggested approach from the U.S. Preventive Services Task Force. Prev. Med. 26 (2004) 56-66
46. Whitlock E., Orleans C., Pender N., et al. Evaluating primary care behavioral counseling interventions: An evidence-based approach. Am. J. Prev. Med. 22 (2002) 267-284
47. Roter D., Hall J., Merisca R., et al. Effectiveness of interventions to improve patient compliance: A meta-analysis. Med. Care 36 (1998) 1138-1161
48. Greenfield S., Kaplan S., and Ware J. Expanding patient involvement in care: Effects on patient outcomes. Ann. Intern. Med. 102 (1985) 520-528
49. Bertakis K. The communication of information from physician to patient: A method for increasing patient retention and satisfaction. J. Fam. Pract. 5 (1997) 217-222
50. Morris J., and Royle G. Offering patients a choice of surgery for early breast cancer: A reduction in anxiety and depression in patients and their husbands. Soc. Sci. Med. 26 (1988) 584-585
51. Legg England S., and Evans J. Patient choices and perceptions after and invitation to participate in treatment decisions. Soc. Sci. Med. 34 (1992) 1217-1225
52. Sutton-Tyrrell K., Wildman R., Newman A., et al. Extent of cardiovascular risk reduction associated with treatment of isolated systolic hypertension. Arch. Intern. Med. 163 (2003) 2728-2731
53. Berlowitz D.R., Ash A.S., Hickey E.C., et al. Inadequate management of blood pressure in a hypertensive population. [comment]. N. Engl. J. Med. 339 (1998) 1957-1963
54. O'Connor P.J. Overcome clinical inertia to control systolic blood pressure. Arch. Intern. Med. 163 (2003) 2677-2678
55. Staessen J.A., Gasowski J., Wang J.G., et al. Risks of untreated and treated isolated systolic hypertension in the elderly: Meta-analysis of outcome trials. Lancet 355 (2000) 865-872
56. Black H.R., Elliott W.J., Weber M.A., et al. One-year study of felodipine or placebo for stage 1 isolated systolic hypertension. Hypertension 38 (2001) 1118-1123
57. Blacher J., Staessen J.A., Girerd X., et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch. Intern. Med. 160 (2000) 1085-1089
58. Vaccarino V., Berger A.K., Abramson J., et al. Pulse pressure and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program. Am. J. Cardiol. 88 (2001) 980-986
59. Somes G.W., Pahor M., Shorr R.I., et al. The role of diastolic blood pressure when treating isolated systolic hypertension. Arch. Intern. Med. 159 (1999) 2004-2009
60. Cushman W.C., Materson B.J., Williams D.W., et al. Pulse pressure changes with six classes of antihypertensive agents in a randomized, controlled trial. Hypertension 38 (2001) 953-957
61. ALLHAT officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288 (2002) 2981-2997
62. Chang J.J., Luchsinger J.A., and Shea S. Antihypertensive medication class and pulse pressure in the elderly: Analysis based on the third National Health and Nutrition Examination Survey. Am. J. Med. 115 (2003) 536-542
63. Linjer E., Hedner T., Jonsson B., et al., Stop-2 Hypertension Group. Cost analysis of different pharmacological treatment strategies in elderly hypertensives. Blood Press. 14 (2005) 107-113
64. Farnett L., Mulrow C.D., Linn W.D., et al. The J-curve phenomenon and the treatment of hypertension. Is there a point beyond which pressure reduction is dangerous?. JAMA 265 (1991) 489-495
65. D'Agostino R.B., Belanger A.J., Kannel W.B., et al. Relation of low diastolic blood pressure to coronary heart disease death in presence of myocardial infarction: The Framingham Study. BMJ 303 (1991) 385-389
66. Okumiya K., Matsubayashi K., Wada T., et al. A U-shaped association between home systolic blood pressure and four-year mortality in community-dwelling older men. J. Am. Geriatr. Soc. 47 (1999) 1415-1421
67. Ogihara T. Practitioner's Trial on the Efficacy of Antihypertensive Treatment in the Elderly Hypertension (The PATE-Hypertension Study) in Japan. Am. J. Hypertens. 13 (2000) 461-467
68. Voko Z., Bots M.L., Hofman A., et al. J-shaped relation between blood pressure and stroke in treated hypertensives. Hypertension 34 (1999) 1181-1185
69. Vatten L.J., Holmen J., Kruger O., et al. Low blood pressure and mortality in the elderly: A 6-year follow-up of 18,022 Norwegian men and women age 65 years and older. Epidemiology 6 (1995) 70-73
70. Adler A.I., Stratton I.M., Neil H.A., et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): Prospective observational study. BMJ 321 (2000) 412-419
71. Hansson L., Zanchetti A., Carruthers S.G., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet 351 (1998) 1755-1762